Feng Zhixian, Huang Jinwen, Xu Yi, Zhang Minming, Hu Shaohua
Department of Nursing, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
J Int Med Res. 2013 Feb;41(1):239-43. doi: 10.1177/0300060513475384. Epub 2013 Jan 23.
Clarithromycin and rabeprazole are both valued for their safety profile. Very few cases of adverse side-effects related to these drugs, when given individually, have been reported; serious side-effects of clarithromycin in combination with rabeprazole have never been reported. The present case reports on a 51-year-old woman with gastritis who received clarithromycin combined with rabeprazole for Helicobacter pylori infection. After taking 500 mg clarithromycin and 10 mg rabeprazole orally she displayed acute psychotic symptoms of dissociative disorder, including: impairment of orientation and attention; the feeling of dreaming; disintegration of thinking; stereotyped speech; flattened emotion; amnesia. Routine blood investigations, computed tomography scans and electroencephalography showed no abnormalities. All symptoms disappeared without antipsychotic treatment ≈ 48 h after she had taken the two drugs. Combining clarithromycin with rabeprazole might increase the risk of neurotoxicity, particularly in susceptible individuals. This should be a concern in clinical practice.
克拉霉素和雷贝拉唑因其安全性而受到重视。单独使用这两种药物时,很少有与药物相关的不良副作用报告;克拉霉素与雷贝拉唑联合使用的严重副作用从未有过报告。本病例报告了一名51岁患有胃炎的女性,因幽门螺杆菌感染接受克拉霉素联合雷贝拉唑治疗。口服500毫克克拉霉素和10毫克雷贝拉唑后,她出现了分离性障碍的急性精神病症状,包括:定向和注意力障碍;梦境感;思维解体;刻板言语;情感平淡;失忆。常规血液检查、计算机断层扫描和脑电图检查均未发现异常。在服用这两种药物约48小时后,所有症状在未进行抗精神病治疗的情况下消失。克拉霉素与雷贝拉唑联合使用可能会增加神经毒性风险,尤其是在易感个体中。这在临床实践中应引起关注。